Lawsuit targets Actavis plants (The Record)
NEW YORK U.S. attorneys in New Jersey on Friday filed a lawsuit seeking a shutdown of three Actavis Inc. plants until they are brought into compliance with testing, manufacturing laws and FDA regulations.

US Attorney requests Actavis plants be shut until repeated FDA violations are addressed (Minneapolis-St. Paul Star Tribune)
NEW YORK - U.S. Attorneys in New Jersey on Friday filed a lawsuit seeking a shutdown of three Actavis Inc. plants until they are brought into compliance with testing, manufacturing laws and FDA regulations.

FDA Approves Low-dose Regimen Of Premarin Vaginal Cream To Treat Moderate To Severe Postmenopausal Dyspareunia Painful ... (Medical News Today)
PREMARIN (conjugated estrogens) Vaginal Cream 0.5 g has been approved by the U.S. Food and Drug Administration (FDA) for a new indication and a new less frequent twice-weekly dosing regimen to treat moderate to severe postmenopausal dyspareunia (painful sexual intercourse) announced Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE).